ITLN1 and breast carcinoma: The right pane focuses on biochemical assay and genotyping for breast cancer (BC) and control groups, featuring pie charts for genotyping of CD295 and ITLN1, highlighted tests like insulin and leptin, and a comet assay with red fluorescent images.